146 related articles for article (PubMed ID: 38651779)
1. Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
Fukuda T; Yamazaki H; Miyatani Y; Sawada T; Shibuya N; Fukuo Y; Kiyohara H; Morikubo H; Tominaga K; Kakimoto K; Imai T; Yaguchi K; Yamamoto S; Ando K; Nishimata N; Yoshihara T; Andoh A; Hibi T; Matsuoka K;
Aliment Pharmacol Ther; 2024 Jul; 60(1):43-51. PubMed ID: 38651779
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
[TBL] [Abstract][Full Text] [Related]
3. Risk of Relapse in Patients With Ulcerative Colitis With Persistent Endoscopic Healing: A Durable Treatment Endpoint.
Jangi S; Holmer AK; Dulai PS; Boland BS; Collins AE; Pham L; Sandborn WJ; Singh S
J Crohns Colitis; 2021 Apr; 15(4):567-574. PubMed ID: 32914194
[TBL] [Abstract][Full Text] [Related]
4. Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
Seong G; Song JH; Kim JE; Kim TJ; Kim ER; Hong SN; Chang DK; Kim SH; Ha SY; Kim YH
Inflamm Bowel Dis; 2023 Feb; 29(2):238-244. PubMed ID: 35396998
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1.
Fukuda T; Naganuma M; Sugimoto S; Ono K; Nanki K; Mizuno S; Kimura K; Mutaguchi M; Nakazato Y; Takabayashi K; Inoue N; Ogata H; Iwao Y; Kanai T
Inflamm Bowel Dis; 2019 Mar; 25(4):782-788. PubMed ID: 30265308
[TBL] [Abstract][Full Text] [Related]
6. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
[TBL] [Abstract][Full Text] [Related]
8. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
Herfarth H; Barnes EL; Valentine JF; Hanson J; Higgins PDR; Isaacs KL; Jackson S; Osterman MT; Anton K; Ivanova A; Long MD; Martin C; Sandler RS; Abraham B; Cross RK; Dryden G; Fischer M; Harlan W; Levy C; McCabe R; Polyak S; Saha S; Williams E; Yajnik V; Serrano J; Sands BE; Lewis JD;
Gastroenterology; 2018 Oct; 155(4):1098-1108.e9. PubMed ID: 29964043
[TBL] [Abstract][Full Text] [Related]
10. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
Carbonnel F; Colombel JF; Filippi J; Katsanos KH; Peyrin-Biroulet L; Allez M; Nachury M; Novacek G; Danese S; Abitbol V; Bossa F; Moreau J; Bommelaer G; Bourreille A; Fumery M; Roblin X; Reinisch W; Bouhnik Y; Brixi H; Seksik P; Malamut G; Färkkilä M; Coulibaly B; Dewit O; Louis E; Deplanque D; Michetti P; Sarter H; Laharie D; ;
Gastroenterology; 2016 Feb; 150(2):380-8.e4. PubMed ID: 26632520
[TBL] [Abstract][Full Text] [Related]
12. Histological healing as a predictor of sustained clinical remission in paediatric ulcerative colitis.
Scarallo L; Fioretti L; Paci M; Naldini S; Renzo S; Barp J; Gissi A; Di Paola M; Villanacci V; Lionetti P
Dig Liver Dis; 2024 Jan; 56(1):43-49. PubMed ID: 37455156
[TBL] [Abstract][Full Text] [Related]
13. Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Yoon H; Jangi S; Dulai PS; Boland BS; Prokop LJ; Jairath V; Feagan BG; Sandborn WJ; Singh S
Gastroenterology; 2020 Oct; 159(4):1262-1275.e7. PubMed ID: 32585306
[TBL] [Abstract][Full Text] [Related]
14. Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in ulcerative colitis.
Papamichael K; Rakowsky S; Rivera C; Cheifetz AS; Osterman MT
Aliment Pharmacol Ther; 2018 Feb; 47(4):478-484. PubMed ID: 29210094
[TBL] [Abstract][Full Text] [Related]
15. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
[TBL] [Abstract][Full Text] [Related]
16. Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis?: a prospective study.
Parente F; Molteni M; Marino B; Colli A; Ardizzone S; Greco S; Sampietro G; Foschi D; Gallus S
Am J Gastroenterol; 2010 May; 105(5):1150-7. PubMed ID: 19997096
[TBL] [Abstract][Full Text] [Related]
17. Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort.
Bossuyt P; Baert F; D'Heygere F; Nakad A; Reenaers C; Fontaine F; Franchimont D; Dewit O; Van Hootegem P; Vanden Branden S; Lambrecht G; Ferrante M;
Inflamm Bowel Dis; 2019 Jan; 25(1):156-162. PubMed ID: 29920582
[TBL] [Abstract][Full Text] [Related]
18. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
Schmidt KJ; Müller N; Dignass A; Baumgart DC; Lehnert H; Stange EF; Herrlinger KR; Fellermann K; Büning J
J Crohns Colitis; 2016 Jan; 10(1):31-7. PubMed ID: 26419459
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
Fron C; Pierry C; Poullenot F; Chabrun E; Subtil C; Capdepont M; Zerbib F; Belleannée G; Laharie D
Dig Liver Dis; 2016 Jul; 48(7):734-9. PubMed ID: 27052254
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
